Spanish Red Biotech Pipeline

Amgen

carfilzomib

Type: Biodrugs/ Drugs
Therapeutic area: Blood and Lymphatic systems
Cancer
Indication: Relapsed or refractory multiple myeloma
Phase: 3Phase III in Spain, 2Phase II in Spain, 1Phase I in Spain